home-infusion-therapy-market

Home Infusion Therapy Market By Product, By Therapy, By Route of Administration - Growth, Share, Opportunities & Competitive Analysis, 2024 - 2032

17 May 2023 Format PDF icon PPT icon XLS icon Request Sample

Home Infusion Therapy Market is Expected to Grow at 7.5% by 2031. Home infusion therapy refers to administration of biological and drugs in patient’s home, wither by patient themselves, family, nurse and others. Home infusion services include patient training and education, administration, care coordination, pharmacy services and others. These services and supplies are usually provided by physicians and pharmacy staff, where initially, the patient picks up medications form physician’s office. Nursing services for home care are also provided through agencies.

Geriatric population is the largest consumer of home infusion therapy. As the global population is ageing, this population possesses a high risk and susceptibility of this population group to develop chronic conditions that require infusion therapy. Growing demand for home healthcare by disabled patient group will additionally widen the base for home infusion therapy. Augmenting use of home infusion therapy also results in reduction in hospital readmission and in-patient stay, thus containing healthcare costs. Home infusion therapy is also instrumental in reducing the risk of contracting nosocomial infection thus presenting a potential market penetration opportunity.

Key players identified for the healthcare analytical testing market include but are not limited to:

  • CVS/Coram

  • Option Care Health

  • CareFusion Corporation

  • BriovaRx/Diplomat (UnitedHealth Optum)

  • PharMerica

  • Fresenius Kabi

  • ICU Medical, Inc.

  • B. Braun Melsungen AG

  • Baxter

  • BD

  • Caesarea Medical Electronics

  • Smiths Medical

  • Terumo Corporation

  • JMS Co. Ltd.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Home Infusion Therapy market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Home Infusion Therapy market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

ATTRIBUTE DETAILS
Research Period  2022-2032
Base Year 2023
Forecast Period  2024-2032
Historical Year  2022
Unit  USD Million
Segmentation
Product Type
  • Infusion Pumps
    •     Elastomeric Pumps
    •     Electromechanical
    •     Gravity
    •     Others
  • IV Sets
  • IV Cannulas
  • Needleless Connectors

Therapy Type
  • Anti-infective
  • Endocrinology
    •     Diabetes
    •     Others
  • Hydration Therapy
    •     Athletes
    •     Others
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Others

Route of Administration
  • Intramuscular
  • Subcutaneously
  • Epidural

 Region Segment (2022-2032; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Home Infusion Therapy market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2032.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Home Infusion Therapy market?
  • Which is the largest regional market for Home Infusion Therapy market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Home Infusion Therapy market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Home Infusion Therapy market worldwide?
Choose Licence Type
$4500
$6500
$9000
Why Acute
View Other Reports